Introduction to Market Access for Pharmaceuticals
Seiten
2016
Apple Academic Press Inc. (Verlag)
978-1-4822-0440-7 (ISBN)
Apple Academic Press Inc. (Verlag)
978-1-4822-0440-7 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the correct purchasers, the drug will fail to reach its intended market. This practical guide, from the European Market Access University Diploma (EMAUD), helps readers draft a market access strategy for their product and prepare a positive healthcare environment that supports uptake of the product, including pricing considerations.
General Facts About Market Access. Healthcare Market Specificities. General Concept of Market Access. Market Access in the Pharmaceutical IndustryWhy is Market Access Important? Payers. A Complex Interface. HTA: Value Beyond the Price. Pricing and Reimbursement. Market Access Agreements. Market Access specificities. Market Access along the Entire Drug Development Chain. Before Phase I. Phase I/II. Phase III. At Filing for Marketing Authorization. After Marketing Authorization Approval. Life Cycle Management.
| Verlagsort | Oakville |
|---|---|
| Sprache | englisch |
| Maße | 210 x 280 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Medizin / Pharmazie ► Pflege | |
| Technik | |
| ISBN-10 | 1-4822-0440-1 / 1482204401 |
| ISBN-13 | 978-1-4822-0440-7 / 9781482204407 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
CHF 149,95
Englisch für Apotheker und PTAs
Buch | Spiralbindung (2024)
Kohlhammer (Verlag)
CHF 44,75